(HealthDay News) — The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to a study published online in the Journal of General Internal ...

Area under receiver operating characteristic curve improved with retinal parameters, outperforming traditional risk factors ...

(HealthDay News) — Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products. Nicotine pouches — small synthetic ...

Consuming up to 4 cups per day associated with lower all-cause mortality among patients with CKD stage 1 to 2. (HealthDay News) — Tea consumption offers protective effects on mortality among patients ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines ...

For individuals reporting past-year cannabis use, decreased odds of opioid misuse observed in states with medical cannabis legalization ...

(HealthDay News) — Cancer mortality is continuing to decline, but the incidence of certain cancer types is increasing, especially among women, according to the Cancer Statistics, 2025 report published ...

Increased cancer incidence seen in digestive, endocrine, oral cavity/pharynx, and respiratory systems between 2016 and 2021 ...

Vitamin D3 supplementation was associated with antihypertensive effects without significant between-dose differences among overweight older adults.

Caution is urged with early albumin use in septic shock and kidney impairment, especially with hyperoncotic vs isooncotic albumin.

Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.